Krystal Biotech

-$1.29 (-2.18%) Today

$0.00 (0.00%) As of 9:26 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell KRYS and other ETFs, options, and stocks.

About KRYS

Krystal Biotech, Inc. is a clinical-stage biotechnology company, which focuses on the development of redosable gene therapies to improve the lives of patients living with rare diseases. The firm developed a proprietary gene delivery platform that enables off-the-shelf treatments for serious rare diseases with significant unmet need, initially in the areas of dermatology and respiratory diseases.

CEO

Krish S. Krishnan

Employees

119

Headquarters

Pittsburgh, Pennsylvania

Founded

2016

KRYS Key Statistics

Market cap

Price-Earnings ratio

—

Dividend yield

—

Average volume

178.06K

High today

$60.44

Low today

$57.23

Open price

$60.17

Volume

91.03K

52 Week high

$102.99

52 Week low

$38.86

KRYS News

Simply Wall StMay 17

Here's What Krystal Biotech, Inc.'s Shareholder Ownership Structure Looks Like - Simply Wall St

A look at the shareholders of Krystal Biotech, Inc. ( ) can tell us which group is most powerful. Institutions will often hold stock in bigger companies, and we

Analyst ratings

Buy

100%

Hold

Sell

KRYS Earnings

-$0.99

-$0.66

-$0.33

$0.00

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Estimated

— per share

Actual

-$0.99 per share